Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

June 01, 2008 (Vol. 28, No. 11)

Norway's Oncology Efforts Are Coalescing

The Oslo Cancer Cluster Is at the Heart of a Burgeoning Movement

  • Most biotech companies in Norway are focused upon oncology, and 80% of the nation’s cancer research is located in or around the capital. Therefore, the formation of the Oslo Cancer Cluster (OCC), a partnership between industry, research institutions, government, and the Norwegian Cancer Society is a logical development. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.